News
Spoiler alert! This story contains details from the series finale of "The Handmaid's Tale." Gilead hasn't fallen quite yet, but June Osborne will keep fighting however she can. The quiet ...
The ending saw a proper rebellion in a world where the totalitarian, patriarchal government of Gilead is wounded, but not destroyed. In Boston? Yes. Gilead is no longer occupying the city after ...
Clovis, California, Mayor Pro Tem Diane Pearce spoke to Fox News Digital about her city hosting the state track and field championships, which drew scrutiny from Trump’s administration over a ...
A $4.9 billion hole has appeared in Gilead Sciences' pipeline. After years of setbacks, the Big Biotech dealt a final blow to its anti-CD47 monoclonal antibody magrolimab Thursday by removing the ...
Gilead helped pioneer HIV care by developing options to treat and prevent the disease. Curing HIV remains an ultimate aspiration of Gilead’s HIV research and development efforts, and we are ...
April 4 (Reuters) - Gilead Sciences Inc (GILD.O), opens new tab on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy ...
Aug 3 (Reuters) - Gilead Sciences (GILD.O), opens new tab on Thursday reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 treatment offset ...
Brian Heath has joined Gilead Sciences’ cell therapy subsidiary as a senior vice president and head of global commercial, he announced on LinkedIn this week. “CAR T-cell therapy has changed ...
Gilead will fund the construction of three facilities, upgrades to three others and investments in technology and engineering. (Bloomberg News) Gilead Sciences said Wednesday it will invest $11 ...
Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of growth beyond its core portfolio of HIV medicines. Merdad Parsey ...
Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and adolescent girls in Africa, the first successful big trial of what’s hoped to become a powerful ...
Gilead Sciences Inc. has found a new general counsel to succeed the biopharma company's longtime legal boss. The Foster City, California-based company announced Tuesday that it had hired Deborah ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results